Latest Reports

Market Scope surveyed ophthalmologists and optometrists in the US and Western Europe (WE) during July and August 2025 to measure patients they were seeing and screening for ocular surface disease; adoption of treatments; and insight into the latest market trends. 

Ophthalmologists and optometrists from most specialties (cataract, refractive, retina, dry eye glaucoma, and comprehensive) who self-registered on market-scope.com were invited to participate in the annual sponsored survey. 

An email invitation was sent on July 25, 2025, and a last call went out on Aug. 8, 2025. We received 198 total complete, unique responses—158 from the US and 40 from WE. All results were calculated based on respondent count; because not all questions were applicable to all providers, the respondent count (n) may vary throughout the survey. 

Survey reports are strictly a summary analysis of the reported data, and no additional extrapolation to the overall market was performed. All survey data are de-identified and maintained on a secure server. 

The “2025 Fundus Imaging Market Report” delivers an in-depth look at one of the fastest-evolving segments of ophthalmic diagnostics, expanding on the fundus imaging coverage from Market Scope’s global Ophthalmic Diagnostic Equipment Market Report.

This specialized edition provides detailed analyses of market performance, competitive positioning, and technology trends across five product categories—fundus screeners, diagnostic fundus imaging, advanced fundus imaging, combination systems, and hand-held devices. It includes comprehensive estimates of unit sales, installed base, average selling prices, and manufacturer participation, offering a complete view of the market landscape and its growth trajectory through 2030.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report” is the definitive resource for understanding the global ophthalmic diagnostic landscape. This edition delivers in-depth analysis of the current markets for diagnostic equipment in cataract and refractive surgery, refracting and screening instruments, and emerging technologies. It also provides five-year global forecasts, along with regional and economic analyses across the US, Western Europe, Japan, other wealthy nations, China, India, Latin America, and developing markets worldwide. 

The report considers more than 800 devices from 115 manufacturers, covering technologies that span corneal topographers, anterior eye scanners, biometers, tonometers, fundus cameras, perimeters, refractors, slit lamps, and advanced microscopy systems. 

Each section includes market sizing, pricing trends, competitor market share, installed equipment base, and company profiles, giving manufacturers, investors, and eye care providers the actionable intelligence needed to navigate competitive dynamics, plan strategic growth, and anticipate technological innovation.  

The 2025 Refractive Surgery Market Report provides a comprehensive view of the global refractive and presbyopia-correcting surgical market, highlighting the trends, drivers, and opportunities shaping the next five years. The report analyzes LASIK, lenticular extraction, phakic IOLs, refractive lens exchange (RLE), and emerging technologies poised to disrupt the market. 

It examines key participants in this segment, including prospective patients, refractive surgeons, laser centers, manufacturers of excimer and femtosecond lasers, mechanical microkeratomes, diagnostic equipment, and other presbyopia-correcting technologies.  

The report provides unit and revenue forecasts, market share analysis, and in-depth profiles of 15 leading competitors, including product portfolios, strategic positioning, company background, and outlook. 

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

The “2025 Glaucoma Surgical Device Market Report” provides a data-driven analysis of the global market for glaucoma surgical devices, offering comprehensive coverage of current technologies, innovation pipelines, competitive positioning, and growth opportunities by region. 

The report examines global glaucoma prevalence and treatment trends. It details the full spectrum of commercialized devices—including microstents, subconjunctival shunts, canal surgery devices, and tube shunts—and evaluates the pipeline of investigational products that are poised to improve outcomes and drive future adoption. 

Market demand is forecast in both units and dollars through 2030, with detailed segmentation by device category, procedure type, and region. Competitive analysis includes market share estimates, plans for product adoption, and detailed profiles of 29 leading and emerging companies, highlighting their products, strategic positioning, and outlook in this rapidly evolving segment.